Aromatase inhibitors as adjuvant therapy for breast cancer.
作者信息
Montemurro Filippo, Aglietta Massimo, Del Mastro Lucia
出版信息
J Clin Oncol. 2009 May 20;27(15):2566-7. doi: 10.1200/JCO.2009.22.2695. Epub 2009 Mar 30.
PMID:19332706
Abstract
摘要
相似文献
1
Aromatase inhibitors as adjuvant therapy for breast cancer.芳香化酶抑制剂作为乳腺癌的辅助治疗
J Clin Oncol. 2009 May 20;27(15):2566-7. doi: 10.1200/JCO.2009.22.2695. Epub 2009 Mar 30.
2
Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence?使用辅助性芳香化酶抑制剂降低早期复发率：证据有哪些？
Breast. 2008 Aug;17(4):353-60. doi: 10.1016/j.breast.2008.02.003. Epub 2008 May 19.
3
Absolute benefits of aromatase inhibitors in adjuvant treatment of breast cancer: should we know more?芳香化酶抑制剂在乳腺癌辅助治疗中的绝对获益：我们是否应了解更多？
J Clin Oncol. 2010 Jul 10;28(20):e346-7; author reply e348. doi: 10.1200/JCO.2010.28.3564. Epub 2010 May 10.
4
Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.芳香化酶抑制剂作为乳腺癌辅助治疗：在临床实践中以总生存期与无病生存期作为主要终点
J Clin Oncol. 2009 Dec 10;27(35):e255-6; author reply e257-8. doi: 10.1200/JCO.2009.25.3914. Epub 2009 Nov 2.
5
The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.早期乳腺癌辅助激素治疗的最佳持续时间。
Clin Adv Hematol Oncol. 2008 Aug;6(8):573-4.
6
Aromatase inhibitors for breast cancer prevention.用于预防乳腺癌的芳香化酶抑制剂
J Clin Oncol. 2005 Mar 10;23(8):1636-43. doi: 10.1200/JCO.2005.11.027.
7
Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy.个体化乳腺治疗：为优化辅助内分泌治疗定制药物和生物标志物
Breast Cancer Res Treat. 2010 Apr;120(2):437-9. doi: 10.1007/s10549-010-0787-1. Epub 2010 Feb 17.
8
Optimum use of aromatase inhibitors in the adjuvant treatment of early breast cancer.芳香化酶抑制剂在早期乳腺癌辅助治疗中的优化应用。
J Clin Oncol. 2005 Nov 20;23(33):8544-6; author reply 8546-7. doi: 10.1200/JCO.2005.03.7416.
9
Comparing aromatase inhibitors in the absence of clinical trial results can be misleading.在缺乏临床试验结果的情况下比较芳香化酶抑制剂可能会产生误导。
J Surg Oncol. 2007 Mar 15;95(4):355-6; author reply 357. doi: 10.1002/jso.20710.
10
Aromatase inhibitors in breast cancer.乳腺癌中的芳香化酶抑制剂
N Engl J Med. 2003 Jun 12;348(24):2431-42. doi: 10.1056/NEJMra023246.
引用本文的文献
1
Investigation of genotoxicity risk and DNA repair capacity in breast cancer patients using anastrozole.使用阿那曲唑对乳腺癌患者的遗传毒性风险和DNA修复能力进行研究。
North Clin Istanb. 2018 Jan 22;5(1):6-13. doi: 10.14744/nci.2017.55822. eCollection 2018.
2
Phosphorylation by p38 mitogen-activated protein kinase promotes estrogen receptor α turnover and functional activity via the SCF(Skp2) proteasomal complex.p38 丝裂原活化蛋白激酶的磷酸化通过 SCF(Skp2)蛋白酶体复合物促进雌激素受体 α 的降解和功能活性。
Mol Cell Biol. 2012 May;32(10):1928-43. doi: 10.1128/MCB.06561-11. Epub 2012 Mar 19.
Zotero 插件